185 related articles for article (PubMed ID: 30086781)
1. Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology.
Hu L; Du J; Lv H; Zhao J; Chen M; Wang Y; Wu F; Liu F; Chen X; Zhang J; Ma H; Jin G; Shen H; Chen L; Ling X; Hu Z
Reprod Biol Endocrinol; 2018 Aug; 16(1):74. PubMed ID: 30086781
[TBL] [Abstract][Full Text] [Related]
2. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
[TBL] [Abstract][Full Text] [Related]
3. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
5. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
[TBL] [Abstract][Full Text] [Related]
6. Cumulative live birth rates following miscarriage in an initial complete cycle of IVF: a retrospective cohort study of 112 549 women.
Cameron NJ; Bhattacharya S; Bhattacharya S; McLernon DJ
Hum Reprod; 2017 Nov; 32(11):2287-2297. PubMed ID: 29040570
[TBL] [Abstract][Full Text] [Related]
7. Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1 376 454 cycles recorded by the Human Fertilisation and Embryology Authority (1991-2016).
Allen C; McLernon D; Bhattacharya S; Maheshwari A
Hum Reprod; 2023 Jun; 38(6):1194-1201. PubMed ID: 36961939
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study.
Gerber RS; Fazzari M; Kappy M; Cohen A; Galperin S; Lieman H; Jindal S; Buyuk E
Fertil Steril; 2020 Dec; 114(6):1225-1231. PubMed ID: 33012553
[TBL] [Abstract][Full Text] [Related]
9. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
10. Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).
Ata B; Abou-Setta AM; Seyhan A; Buckett W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011809. PubMed ID: 29489026
[TBL] [Abstract][Full Text] [Related]
11. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
12. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
Dong L; Lian F; Wu H; Xiang S; Li Y; Wei C; Yu X; Xin X
BMC Pregnancy Childbirth; 2022 Jul; 22(1):583. PubMed ID: 35869444
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes after assisted human reproduction.
Okun N; Sierra S; ;
J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
[TBL] [Abstract][Full Text] [Related]
14. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
[TBL] [Abstract][Full Text] [Related]
15. The risks of birth defects and childhood cancer with conception by assisted reproductive technology.
Luke B; Brown MB; Wantman E; Schymura MJ; Browne ML; Fisher SC; Forestieri NE; Rao C; Nichols HB; Yazdy MM; Gershman ST; Sacha CR; Williams M; Ethen MK; Canfield MA; Doody KJ; Eisenberg ML; Baker VL; Williams C; Sutcliffe AG; Richard MA; Lupo PJ
Hum Reprod; 2022 Oct; 37(11):2672-2689. PubMed ID: 36112004
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic early ovarian ageing: risk of miscarriage and chance of delivery following ART in a nationwide cohort study.
Christensen MW; Ingerslev HJ; Kirkegaard K; Kesmodel US
Hum Reprod; 2022 Jul; 37(8):1856-1870. PubMed ID: 35522192
[TBL] [Abstract][Full Text] [Related]
17. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
Martins WP; Vieira AD; Figueiredo JB; Nastri CO
Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
[TBL] [Abstract][Full Text] [Related]
18. Paternal age over 50 years decreases assisted reproductive technology (ART) success: A single UK center retrospective analysis.
Morris G; Mavrelos D; Odia R; Viñals Gonzalez X; Cawood S; Yasmin E; Saab W; Serhal P; Seshadri S
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1858-1867. PubMed ID: 34405396
[TBL] [Abstract][Full Text] [Related]
19. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology.
Tatsumi T; Jwa SC; Kuwahara A; Irahara M; Kubota T; Saito H
Hum Reprod; 2017 Jan; 32(1):125-132. PubMed ID: 27821708
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
